DALLAS, June 27, 2017 /PRNewswire/ --
Puration, Inc. (USOTC: PURA) last week announced the Company entering into a letter of intent agreement to acquire a grow operation with an existing twenty-five greenhouse facility anticipated to add $1 million in annual revenue with the potential to expand to $16 million in annual revenue.
Drug Emporium, EVERx CBD Infused Citrus Cooler Flavored Water, and EVERx CBD Infused Orange Flavored Water
PURA continues to grow its cannabis infused beverage business. The cannabis infused beverage business will continue to include both the expansion of the PURA in-house EVERx beverage line in addition to providing extracts for third party beverages. Besides closing its first major retail chain distribution agreement with Drug Emporium for its EVERx CBD Infused Sports Water, PURA also recently announced its EVERx CBD Infused Citrus Cooler Flavored Sports Water, the first of three-planned flavored EVERx CBD Infused Sports Waters. The Company has produced its first Citrus Cooler Flavored CBD Infused Sports Water and is currently market testing the product. Today, the Company is for the first time announcing the addition of an EVERx CBD Infused Orange Flavored Sports Water. Management anticipates the first EVERx CBD Infused Orange Flavored Sports Water being produced and market tested by the end of July.
AmeriCanna Cafe Cannabis Infused Beverages, and Spanish Peaks ScrumpDelicacies Cannabis Infused Beverages
PURA continues to work with North American Cannabis Holdings (USOTC: USMJ) to develop USMJ's own AmeriCanna Cafe line of cannabis infused beverages in addition to working with Spanish Peaks ScrumpDelicacies to develop a line of Spanish Peaks cannabis infused beverages. First product announcements of each are anticipated soon.
Anticipated Sales Growth Acceleration In Q3 and Q4 2017
Management anticipates substantial sales growth in the 3rd and 4th fiscal quarters of 2017 from the combination of its ongoing cannabis infused beverage sales and the impending new addition of its grow operation sales.
Learn More About PURA: http://www.purationinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Brian Shibley, CEO
SOURCE Puration, Inc.